
GH Research rose 23.3% from $15.00 to $18.49, ahead of the S&P 500's +10.8%. Its worst day was Jan 8 (−13.4%), and its low came Dec 15 at $12.49.
Nov 12, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
GH Research closed at its lowest level of the year, 16.8% below where the year started.
−4.2% · S&P 500 −0.2%
GH Research shares rose 27.1%, while the S&P 500 fell 0.3%.
+27.1%, the year's best day · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
GH Research shares fell 12.1%, while the S&P 500 fell 1.2%.
−12.1% · S&P 500 −1.2%
EPS of $-0.23 beat the $-0.28 estimate on $0.00 revenue.
−5.1% · S&P 500 −0.6%
GH Research shares rose 17.2%, while the S&P 500 fell 0.2%.
+17.2% · S&P 500 −0.2%
EPS of $-0.31 missed the $-0.26 estimate on $0.00 revenue.
+1.5% · S&P 500 +0.8%
GH Research shares rose 11.4%, while the S&P 500 fell 0.7%.
+11.4% · S&P 500 −0.7%
EPS of $-0.23 beat the $-0.32 estimate on $0.00 revenue.
+5.2% · S&P 500 −0.2%
Where it ended: a close of $18.49 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.30).
Nothing in the past 12 months.
All GHRS dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GHRS and SPY from Benzinga historical bars. Not investment advice.